Physician profile
Lee Besen
NPI 1770559213
$1,609.61
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $903 · 2020: $707.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $740.71 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $291.37 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $258.66 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $67.14 | 2019 | |
| Sunovion Pharmaceuticals INC. | $57.27 | 2019 | |
| Glaxosmithkline, LLC. | $54.56 | 2019-2020 | |
| Radius Health, INC. | $25.77 | 2019-2020 | |
| Amgen INC. | $24.64 | 2019 | |
| Tactile Systems Technology INC | $20.32 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.90 | 2020 | |
| Lilly USA, LLC | $14.61 | 2019 | |
| Genentech USA, INC. | $14.57 | 2020 | |
| Sanofi-Aventis U.S. LLC | $13.29 | 2020 | |
| Novartis Pharmaceuticals Corporation | $11.80 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Besen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.